《Table 1 Comparison of lateral flow strip test and conventional method (ELISA) for RAC detection in
本系列图表出处文件名:随高清版一同展现
《一种新型莱克多巴胺-蛋白质载体结合技术在侧向流试纸条检测动物饲料中莱克多巴胺含量中的应用(英文)》
The values of RAC concentrations are expressed as mean±SD
To test the practical applicability of the strip test,RAC spiked into animal feed at 0.10,0.25,and0.50 ng/g was measured to calculate for percent recovery and relative standard derivation(RSD)percentage using an independent strip test on the same day(intra-assay)and on three different days(interassay),and the values obtained were compared with those obtained using the conventional method(ELISA)as summarized in Table 1.The intra-assay(n=6)recovery percentage was in the range of 96.9–100.2with RSD of 2.5%–2.8%,and the inter-assay(n=3)recovery percentage was 96.4–103.7 with an RSD of 3.1%–3.6%.The results demonstrated smaller RSD percentages for both intra-and inter-assays,demonstrating the precision of the developed method.To compare the results obtained using the strip test with those obtained using ELISA,a paired t-test at a95%confidence interval was used for animal feed analysis.The calculated t-value obtained by the strip test was lower than the critical t-value,indicating no significant difference between the strip test and ELISA.Therefore,the proposed strip test,with high reproducibility and precision,could have strong potential as an alternative device for the early screening of RAC in animal feeds.
图表编号 | XD0047006300 严禁用于非法目的 |
---|---|
绘制时间 | 2019.02.03 |
作者 | Pattarachaya PREECHAKASEDKIT、Nattaya NGAMROJANAVANICH、Nanthika KHONGCHAREONPORN、Orawon CHAILAPAKUL |
绘制单位 | Program in Biotechnology, Faculty of Science, Chulalongkorn University、Electrochemistry and Optical Spectroscopy Center of Excellence (EOSCE), Department of Chemistry, Faculty of Science, Chulalongkorn University、The Institute of Biotechnology and Genetic |
更多格式 | 高清、无水印(增值服务) |
查看“Table 1 Comparison of lateral flow strip test and conventional method (ELISA) for RAC detection in animal feed”的人还看了
- Table 1A comparison of the conventional drug discovery and development process with those of the CAR-based living drug.